Review: taking Nystatin and Probiotic together


Summary

Drug interactions are reported among people who take Nystatin and Probiotic together. This review analyzes the effectiveness and drug interactions between Nystatin and Probiotic. It is created by eHealthMe based on reports of 19 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Nystatin and Probiotic >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Nystatin

Nystatin has active ingredients of nystatin. It is often used in oral candidiasis. (latest outcomes from Nystatin 9,966 users)

Probiotic

Probiotic has active ingredients of bacillus coagulans. It is often used in crohn's disease. (latest outcomes from Probiotic 1,450 users)

On Aug, 24, 2016

19 people who take Nystatin, Probiotic are studied.


Number of reports submitted per year:

Nystatin and Probiotic drug interactions.

Drug effectiveness over time:

Nystatin:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Probiotic:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Nystatin:
  • female: 100.0% - (1 of 1 people)
  • male: 0.0% - (0 of 0 people)
Probiotic:
  • female: 100.0% - (1 of 1 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Nystatin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Probiotic:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

1 - 6 months:
  • candidiasis
  • food allergy
  • food intolerance
2 - 5 years:
  • candidiasis
  • food allergy
  • food intolerance
not specified:
  • urinary tract infection
  • weight decreased
  • nausea
  • pain
  • adverse event
  • bronchitis chronic
  • abortion spontaneous
  • maternal exposure during pregnancy
  • ventricular extrasystoles
  • gastrointestinal haemorrhage

Most common drug interactions by gender *:

female:
  • abortion spontaneous
  • maternal exposure during pregnancy
  • ventricular extrasystoles
  • candidiasis
  • food allergy
  • food intolerance
  • weight decreased
  • nausea
  • pain
  • adverse event
male:
  • gastrointestinal haemorrhage
  • nephrolithiasis
  • urinary tract infection
  • atelectasis
  • chills
  • colitis
  • fungal skin infection
  • hypotension
  • medical device complication
  • mental status changes

Most common drug interactions by age *:

20-29:
  • nephrolithiasis
  • urinary tract infection
30-39:
  • abortion spontaneous
  • maternal exposure during pregnancy
  • ventricular extrasystoles
  • candidiasis
  • food allergy
  • food intolerance
  • abdominal pain
  • diarrhoea
  • gastric disorder
  • gastrointestinal disorder
40-49:
  • hypersensitivity
  • injection site erythema
  • injection site induration
  • injection site reaction
  • injection site swelling
  • therapeutic response decreased
50-59:
  • meningitis aseptic
60+:
  • gastrointestinal haemorrhage
  • adverse event
  • bronchitis chronic
  • cataract
  • confusional state
  • psychomotor hyperactivity
  • urinary tract infection
  • urticaria
  • weight decreased
  • abdominal pain lower

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Nystatin and Probiotic?

Can you answer these questions?

More questions for: Nystatin, Probiotic

You may be interested in these reviews

More reviews for: Nystatin, Probiotic

On eHealthMe, Nystatin (nystatin) is often used to treat oral candidiasis. Probiotic (bacillus coagulans) is often used to treat crohn's disease. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.